The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Iakushina T.I.

Belova Iu.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Cases of pregnancy in patients with aggressive multiple sclerosis treated with natalizumab

Authors:

Iakushina T.I., Belova Iu.A.

More about the authors

Read: 1583 times


To cite this article:

Iakushina TI, Belova IuA. Cases of pregnancy in patients with aggressive multiple sclerosis treated with natalizumab. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(2‑2):94‑97. (In Russ.)
https://doi.org/10.17116/jnevro20191192294

Recommended articles:
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Surgical treatment of seco­ndary trigeminal neuralgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):203-209
Quality of life of patients with multiple scle­rosis in the Smolensk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):36-40
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Epidemiology of multiple scle­rosis in the city of Novo­sibirsk. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):119-127
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107

References:

  1. Yakushina TI, Kotov SV, Yakushin MA. Analysis of the course of pregnancy, delivery and postpartum period in women with multiple sclerosis. Al’manakh Klinicheskoi Meditsin. 2015;39:82-88. (In Russ.) https://doi.org/10.18786/2072-0505-2015-39-82-89
  2. Babenko LA, Malkova NA. Rasseyannyi skleroz: beremennost’ I terapiya preparatami, izmenyayushchimi techenie rasseyannogo skleroza. Materialy X Vserossiiskogo s’ezda nevrologov s mezhdunarodnym uchastiem; 2012. (In Russ.)
  3. Kotov SV, Yakushina TI. Rasseyannyi skleroz i beremennost’. Osobennosti techeniya beremennosti, rodov I poslerodovogo perioda u zhenshchin, stradayushchikh rasseyannym sklerozom. Rezul’taty nablyudenii za patsientami dannoi gruppy v Moskovskoi oblasti. Russian Medical Journal. 2015;12(23):720-724. (In Russ.)
  4. Shmidt TE, Yakhno NN. Rasseyannyi skleroz. Rukovodstvo dlya vrachei. 2-e izd. M.: MEDpress-inform; 2010. (In Russ.)
  5. Popova EV, Kukel TM, Muravin AI, Boyko AN, Murashko AV, Gusev EI. Pregnancy and deliveryin women with multiple sclerosis: a retrospective analysi. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2013;113(10-2):52-56. (In Russ.)
  6. Demina TN, Mailyan EF, Gyul’mamedova ID, Gyul’mamedov VA. Sovremennye vzglyady na immunologiyu gestatsionnogo protsessa. Reproduktivnoe Zdorov’e Zhenshchiny. 2003;1:18-22. (In Russ.)
  7. Dobrodeev KT, Usynin MV, Moskovskaya NB. Immunnaya sistema pri fiziologicheskom techenii beremennosti. Immunologiya. 2001;1:355. (In Russ.)
  8. Devonshire V, Duguette P, Dwosh E, Guimomd C, Sadovnick AD. The immune system and hormones: review and relevance to pregnancy and contraception in women with MS. Int MSJ. 2003;10(2):45-50.
  9. Gilmore W, Arias M, Stroud N, Stek A, McCarthy KA, Correale J. Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patients. J Neurol Sci. 2004;224:69-76. https://doi.org/10.1016/j.jns.2004.06.011
  10. Voskuhl R. Sex hormones and other pregnancy-related factors with therapeutic potential in multiple sclerosis. In: Cohen D., Rudick R., eds. Multiple Sclerosis Therapeutics. London: Martin Dunitz Ltd; 2003. https://doi.org/10.1017/cbo9781139023986.046
  11. Kotov SV, Yakushina TI, Lizhdvoi VYu. Long-term comparative studying efficiency of drugs that change the course of multiple sclerosise. Al’manakh Klinicheskoi Meditsin. 2011;25:37-40. (In Russ.)
  12. Zakharova MN, Lysogorskaia EV, Trushnikova TN, Zhelnin AV. The case-report of progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(8):107-109. (In Russ.) https://doi.org/10.17116/jnevro2018118082107
  13. Haghikia A, Langer-Gould A, Rellensmann G, Haghikia A, Langer-Gould A, Rellensmann G, Schneider H, Tenenbaum T, Elias-Hamp B, Menck S, Zimmermann J, Herbstritt S, Marziniak M, Kümpfel T, Mein I, Plavina T, Gold R, Hellwig K. Natalizumab use during the third trimester of pregnancy. JAMA Neurol. 2014;71(7):891-895. https://doi.org/10.1001/jamaneurol.2014.209

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.